儿童Denys-Drash综合征的基因型-表型相关性研究
结果发现外显子8变异者肾病综合征发病更早、肾衰竭更早且死亡率更高;截短变异多位于外显子9,与Wilms瘤发生显著相关。
要点
- 外显子8变异患儿肾病综合征发病和肾衰竭均早于外显子9变异者。
- 外显子8变异者死亡率高于外显子9变异者(35% vs 9%)。
- 截短变异多位于外显子9,且与Wilms瘤发生显著相关。
核心结论
- 儿童Denys-Drash综合征的临床轨迹与WT1变异所在外显子定位相关。
- 基因组新生儿筛查时代,描绘遗传风险对个体化患者管理至关重要。
研究设计与样本
- 法国全国性回顾性研究,纳入2000至2022年诊断为WT1外显子8或9致病变异的儿童。
主要发现
- 半数患儿表现为肾病综合征,其中57%为先天性,中位发病年龄0.3岁(IQR 0.0-0.6)。
- 外显子8变异者肾病综合征发病显著早于外显子9变异者(P=0.0048)。
- 外显子8变异者肾衰竭更早(0.3 vs 1.4岁;P=0.0001),死亡率更高(35% vs 9%,P=0.02)。
- 超过90%的截短变异位于外显子9,与Wilms瘤发生显著相关(P<0.0015)。
关键数值与推荐
- 外显子8变异者肾衰竭中位年龄0.3岁,外显子9变异者1.4岁(P=0.0001)。
- 外显子8变异者死亡率35%,外显子9变异者9%(P=0.02)。
- 截短变异超过90%位于外显子9,与Wilms瘤发生相关(P<0.0015)。
临床怎么用
- 对WT1外显子8或9变异的Denys-Drash综合征患儿,应根据外显子定位预判肾病综合征发病早晚及肾衰竭风险。
- 外显子8变异患儿需更早关注肾功能进展和死亡风险。
- 外显子9截短变异患儿应加强Wilms瘤监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Denys-Drash syndrome (DDS) is a rare disease typically associated with a triad of early onset nephrotic syndromes (NS), susceptibility to Wilms tumor (WT), and genitourinary structural defects. DDS is caused by Wilms' tumor suppression gene (WT1) variants, with the most frequent variants in exons 8 and 9. This study aimed to evaluate the long-term clinical outcomes and genotype-to-phenotype correlations in a large, multicenter cohort of children with typical DDS. METHODS: We conducted a national retrospective study of all children diagnosed with a pathogenic variant in WT1 exons 8 or 9 in France between 2000 and 2022. RESULTS: Fifty-eight children with DDS and variants in exons 8 (n = 23) and 9 (n = 35) of the WT1 gene were identified. Half of the children presented with NS (57% congenital, median age at presentation 0.3 years [interquartile range, IQR: 0.0-0.6]). Twenty-nine percent of children developed WT at a median age of 1.2 (0.5-2.2) years. Children with a variant in exon 8 developed NS much earlier than those with a variant in exon 9 (P = 0.0048), regardless of the type of genetic variation, leading to earlyier kidney failure (KF) (0.3 vs.1.4 years respectively; P = 0.0001) and higher mortality (35% vs 9%, P = 0.02). More than 90% of the truncating variants were located in exon 9 and were significantly associated with the occurrence of WT compared with the DNA-binding-site variants (P < 0.0015). CONCLUSION: In our cohort, children's DDS clinical trajectory was associated with exon localization. In the era of genomic newborn screening, depicting genetic risk is of utmost importance for personalized patient care.
引用
- Glénisson M, Grapin M, Blanc T, et al. Genotype-Phenotype Correlations in Denys-Drash Syndrome in Children. Kidney Int Rep. 2025. PMID: 40303223. doi:10.1016/j.ekir.2025.01.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。